Open-label Study With Bosentan in Interstitial Lung Disease | NCT00319033 | Trialant

Open-label Study With Bosentan in Interstitial Lung Disease | NCT00319033 | Trialant

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Change from baseline to all assessed time points in 6-minute walk test distance.
Change from baseline to all assessed time points in Borg dyspnea index, FVC and DLco, SpO2 at rest and de-saturation index (6-minute walk distance multiplied by SpO2 mean value).
Transition Dyspnea Index at all assessed time points.
Change from baseline to all assessed time points in SpO2 mean value, time to de-saturation (decrease in SpO2 ≥ 4%), trough SpO2 and area under the curve during 6-minute walk test.

Condition Browse Module

Intervention Browse Module